Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T Cells and Interventional Therapy for Advanced Liver Malignancy
NCT02959151Phase 2Unknown
- Sponsor
- Shanghai Genechem
- Start
- Jul 2016
- Primary completion
- Jan 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CART-BCMA in hepatocellular carcinoma (HCC), pancreatic cancer (PC), colorectal cancer (CRC), sponsored by Shanghai Genechem. Status: unknown.
02
Drugs
CART-BCMA
03
Conditions
hepatocellular carcinoma (HCC)pancreatic cancer (PC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02959151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959151.